HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING

被引：3
|
作者：
SUN, XW
KOULOS, JP
FELIX, JC
FERENCZY, A
RICHART, RM
PATH, TW
WRIGHT, TC
机构：
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL & OBSTET & GYNAECOL,NEW YORK,NY 10032
[2] UNIV SO CALIF,DEPT PATHOL,LOS ANGELES,CA 90089
[3] JEWISH GEN HOSP,DEPT PATHOL,MONTREAL,PQ,CANADA
来源：
LANCET | 1995年 / 346卷 / 8975期
关键词：
D O I：
10.1016/S0140-6736(95)91466-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [31] Evidence for the role of human papillomavirus DNA testing in primary screening fog cervical dysplasia
    Uribe, PS
    Kaplan, KJ
    Zahn, CM
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2005, 48 (01): : 120 - 126
  • [32] Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
    Burger, E. A.
    Ortendahl, J. D.
    Sy, S.
    Kristiansen, I. S.
    Kim, J. J.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (09) : 1571 - 1578
  • [33] Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?
    Swid, Mohammed Amer
    Monaco, Sara E.
    [J]. MODERN PATHOLOGY, 2022, 35 (07) : 858 - 864
  • [34] ARTISTIC: a randomised trial of-human-papillomavirus (HPV) testing in primary cervical screening
    Kitchener, H. C.
    Almonte, M.
    Gilham, C.
    Dowie, R.
    Stoykova, B.
    Sargent, A.
    Roberts, C.
    Desai, M.
    Peto, J.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 (51) : 1 - +
  • [35] Women's intentions to receive cervical cancer screening with primary human papillomavirus testing
    Ogilvie, Gina S.
    Smith, Laurie W.
    van Niekerk, Dirk J.
    Khurshed, Fareeza
    Krajden, Mel
    Saraiya, Mona
    Goel, Vivek
    Rimer, Barbara K.
    Greene, Sandra B.
    Hobbs, Suzanne
    Coldman, Andrew J.
    Franco, Eduardo L.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (12) : 2934 - 2943
  • [36] Human Papillomavirus DNA Testing for Cervical Cancer Screening
    Belinson, Suzanne E.
    Belinson, Jerome L.
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (04) : 215 - 222
  • [37] Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
    E A Burger
    J D Ortendahl
    S Sy
    I S Kristiansen
    J J Kim
    [J]. British Journal of Cancer, 2012, 106 : 1571 - 1578
  • [38] Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing
    Marchadier, Agathe
    Bezannier, Laura
    Barre-Pierrel, Stephanie
    Manceau, Antoine
    Abadie, Audrey A.
    Detournay, Bruno
    [J]. JOURNAL OF MEDICAL SCREENING, 2023, 30 (03) : 113 - 119
  • [39] The psychosocial impact of human papillomavirus testing in primary cervical screening - a study within a randomized trial
    Kitchener, H. C.
    Fletcher, I.
    Robert, C.
    Wheeler, P.
    Almonte, M.
    Maguire, P.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (04) : 743 - 748
  • [40] The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population
    Inoue, M.
    Sakaguchi, J.
    Sasagawa, T.
    Tango, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1007 - 1013
12345